The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder

References

• Barkley RA. ADHD And The Nature Of Self-Control. Guilford Press, NY, USA (1997).
   Google Scholar
• Faraone SV, Perlis RH, Doyle AE et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol. Psychiatry57, 1313–1323 (2005).
   PubMed Web of Science ®Google Scholar
• Barkley RA, Grodzinsky G, DuPaul GJ. Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report. J. Abnorm. Child Psych.20, 163–188 (1992).
   PubMed Web of Science ®Google Scholar
• Arnsten AF, Steere JC, Hunt RD. The contribution of α-2 noradrenergic mechanisms to prefrontal cortical cognitive function: potential significance to attention deficit hyperactivity disorder. Arch. Gen. Psychiatry53, 448–455 (1996).
   PubMed Web of Science ®Google Scholar
• McLean A, Dowson J, Toone B et al. Characteristic neurocognitive profile associated with adult attention-deficit/hyperactivity disorder. Psychol. Med.34, 681–692 (2004).
   PubMed Web of Science ®Google Scholar
• Wilkins AJ, Shallice T, McCarthy R. Frontal lesions and sustained attention. Neuropsychologia25, 359–365 (1987).
   PubMed Web of Science ®Google Scholar
• Woods DL, Knight RT. Electrophysiological evidence of increased distractability after dorsolateral prefrontal lesions. Neurology36, 212–216 (1986).
   PubMed Web of Science ®Google Scholar
• Yamaguchi S, Knight RT. Gating of somatosensory input by human prefrontal cortex. Brain Res.521, 281–288 (1990).
   PubMed Web of Science ®Google Scholar
• Aron AR, Robbins TW, Poldrack RA. Inhibition and the right inferior frontal cortex. Trends Cogn. Sci.8, 170–177 (2004).
   PubMed Web of Science ®Google Scholar
• Godefroy O, Rousseaux M. Divided and focused attention in patients with lesion of the prefrontal cortex. Brain Cogn.30, 155–174 (1996).
   PubMed Web of Science ®Google Scholar
• Manes F, Sahakian BJ, Clark L et al. Decision-making processes following damage to the prefrontal cortex. Brain125, 624–639 (2002).
   PubMed Web of Science ®Google Scholar
• Anderson SW, Bechara A, Damasio H et al. Impairment of social and moral behavior related to early damage in human prefrontal cortex. Nat. Neurosci.2, 1032–1037 (1999).
   PubMed Web of Science ®Google Scholar
• Dickstein SG, Bannon K, Castellanos FX et al. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J. Child Psychol. Psychiatry47, 1051–1062 (2006).
   PubMed Web of Science ®Google Scholar
• Rubia K, Smith AB, Brammer MJ et al. Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD. Am. J. Psychiatry162, 1067–1075 (2005).
   PubMed Web of Science ®Google Scholar
• Bush G, Valera EM, Seidman LJ. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol. Psychiatry57, 1273–1284 (2005).
   PubMed Web of Science ®Google Scholar
• Smith AB, Taylor E, Brammer M et al. Task-specific hypoactivation in prefrontal and temporoparietal brain regions during motor inhibition and task switching in medication-naive children and adolescents with attention deficit hyperactivity disorder. Am. J. Psychiatry163, 1044–1051 (2006).
   PubMed Web of Science ®Google Scholar
• Castellanos FX, Lee PP, Sharp W et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA288, 1740–1748 (2002).
   PubMed Web of Science ®Google Scholar
• Makris N, Biederman J, Valera EM et al. Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb Cortex.17, 1364–1375 (2007).
   PubMed Web of Science ®Google Scholar
• Seidman LJ, Valera EM, Makris N et al. Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging. Biol. Psychiatry60, 1071–1080 (2006).
   PubMed Web of Science ®Google Scholar
• Valera EM, Faraone SV, Murray KE et al. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol. Psychiatry15, 1361–1369 (2007).
   Google Scholar
• Brown AB, Biederman J, Valera EM et al. Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention-deficit/hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.153B, 365–375 (2010).
   PubMedGoogle Scholar
• Durston S, Fossella JA, Casey BJ et al. Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol. Psychiatry10, 678–685 (2005).
   PubMed Web of Science ®Google Scholar
• Casey BJ, Epstein JN, Buhle J et al. Frontostriatal connectivity and its role in cognitive control in parent–child dyads with ADHD. Am. J. Psychiatry164, 1729–1736 (2007).
   PubMed Web of Science ®Google Scholar
• Castellanos FX, Margulies DS, Kelly C et al. Cingulate–precuneus interactions: a new locus of dysfunction in adult attention-deficit/hyperactivity disorder. Biol. Psychiatry63, 332–337 (2008).
   PubMed Web of Science ®Google Scholar
• Makris N, Buka SL, Biederman J et al. Attention and executive systems abnormalities in adults with childhood ADHD: a DT-MRI study of connections. Cereb. Cortex18, 1210 (2008).
   PubMed Web of Science ®Google Scholar
• Shaw P, Eckstrand K, Sharp W et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc. Natl Acad. Sci. USA104, 19649–19654 (2007).
   PubMed Web of Science ®Google Scholar
• Knight RT, Grabowecky MF, Scabini D. Role of human prefrontal cortex in attention control. Adv. Neurol.66, 21–34 (1995).
   PubMedGoogle Scholar
• Robbins TW. Dissociating executive functions of the prefrontal cortex. Philos. Trans. R. Soc. Lond. B Biol. Sci.351, 1463–1471 (1996).
   PubMed Web of Science ®Google Scholar
• Middleton FA, Strick PL. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res. Brain Res. Rev.31, 236–250 (2000).
   PubMed Web of Science ®Google Scholar
• Damasio AR. The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philos. Trans. R. Soc. Lond. B Biol. Sci.351, 1413–1420 (1996).
   PubMed Web of Science ®Google Scholar
• Dias R, Robbins TW, Roberts AC. Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort Test: restriction to novel situations and independence from ‘on-line’ processing. J. Neurosci.17, 9285–9297 (1997).
   PubMed Web of Science ®Google Scholar
• Rolls ET. The orbitofrontal cortex and reward. Cereb. Cortex10, 284–294 (2000).
   PubMed Web of Science ®Google Scholar
• van Veen V, Carter CS. The anterior cingulate as a conflict monitor: fMRI and ERP studies. Physiol. Behav.77, 477–482 (2002).
   PubMed Web of Science ®Google Scholar
• Fuster JM. Unit activity in prefrontal cortex during delayed response performance: Neuronal correlates of transient memory. J. Neurophysiol.36, 61–78 (1973).
   PubMed Web of Science ®Google Scholar
• Funahashi S, Bruce CJ, Goldman-Rakic PS. Mnemonic coding of visual space in the monkey’s dorsolateral prefrontal cortex. J. Neurophysiol.61, 331–349 (1989).
   PubMed Web of Science ®Google Scholar
• Miller EK, Erickson CA, Desimone R et al. Neural mechanisms of visual working memory in prefrontal cortex of the macaque. J. Neurosci.16, 5154–5167 (1996).
   PubMed Web of Science ®Google Scholar
• Funahashi S, Chafee MV, Goldman-Rakic PS. Prefrontal neuronal activity in rhesus monkeys performing a delayed anti-saccade task. Nature365, 753–756 (1993).
   PubMed Web of Science ®Google Scholar
• Boucher L, Palmeri TJ, Logan GD et al. Inhibitory control in mind and brain: an interactive race model of countermanding saccades. Psychol. Rev.114, 376–397 (2007).
   PubMed Web of Science ®Google Scholar
• Buschman TJ, Miller EK. Top-down versus bottom-up control of attention in the prefrontal and posterior parietal cortices. Science315, 1860–1862 (2007).
   PubMed Web of Science ®Google Scholar
• Barraclough DJ, Conroy ML, Lee D. Prefrontal cortex and decision making in a mixed-strategy game. Nat. Neurosci.7, 404–410 (2004).
   PubMed Web of Science ®Google Scholar
• Wallis JD, Anderson KC, Miller EK. Single neurons in prefrontal cortex encode abstract rules. Nature411, 953–956 (2001).
   PubMed Web of Science ®Google Scholar
• Rolls ET, Critchley HD, Mason R et al. Orbitofrontal cortex neurons: role in olfactory and visual association learning. J. Neurophysiol.75, 1970–1981 (1996).
   PubMed Web of Science ®Google Scholar
• Goldman-Rakic PS. Cellular basis of working memory. Neuron14, 477–485 (1995).
   PubMed Web of Science ®Google Scholar
• Arnsten AF, Paspalas CD, Gamo NJ et al. Dynamic Network Connectivity: a new form of neuroplasticity. Trends Cogn. Sci.14(8), 365–375 (2010).
   PubMed Web of Science ®Google Scholar
• Robbins TW, Arnsten AF. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu. Rev. Neurosci.32, 267–287 (2009).
   PubMed Web of Science ®Google Scholar
• Brozoski T, Brown RM, Rosvold HE et al. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science205, 929–931 (1979).
   PubMed Web of Science ®Google Scholar
• Arnsten AF, Goldman-Rakic PS. α-2 adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science230, 1273–1276 (1985).
   PubMed Web of Science ®Google Scholar
• Li B-M, Mei Z-T. Delayed response deficit induced by local injection of the α-2 adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys. Behav. Neural Biol.62, 134–139 (1994).
   PubMedGoogle Scholar
• Wang M, Ramos B, Paspalas C et al. α2A-adrenoceptor stimulation strengthens working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell129, 397–410 (2007).
   PubMed Web of Science ®Google Scholar
• Arnsten AF. Through the looking glass: differential noradrenergic modulation of prefrontal cortical function. Neural Plasticity7, 133–146 (2000).
   PubMed Web of Science ®Google Scholar
• MacDonald E, Kobilka BK, Scheinin M. Gene targeting – homing in on α-2-adrenoceptor subtype function. Trends Pharmacol. Sci.18, 211–219 (1997).
   PubMed Web of Science ®Google Scholar
• Winzer-Serhan UH, Leslie FM. α-2B adrenoceptor mRNA expression during rat brain development. Brain Res. Dev. Brain Res.100, 90–100 (1997).
   PubMedGoogle Scholar
• Buzsaki G, Kennedy B, Solt VB et al. Noradrenergic control of thalamic oscillation: the role of α-2 receptors. Eur. J. Neurosci.3, 222–229 (1991).
   PubMedGoogle Scholar
• Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev.42, 33–84 (2003).
   PubMed Web of Science ®Google Scholar
• Nelson LE, Lu J, Guo T et al. The α2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology98, 428–436 (2003).
   PubMed Web of Science ®Google Scholar
• U’Prichard DC, Bechtel WD, Rouot BM et al. Multiple apparent α-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine. Mol. Pharmacol.16, 47–60 (1979).
   PubMed Web of Science ®Google Scholar
• Arnsten AF, Cai JX, Goldman-Rakic PS. The α-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects. J. Neurosci.8, 4287–4298 (1988).
   PubMed Web of Science ®Google Scholar
• Franowicz JS, Kessler L, Dailey-Borja CM et al. Mutation of the α2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine. J. Neurosci.22, 8771–8777 (2002).
   PubMedGoogle Scholar
• Cai JX, Ma Y, Xu L et al. Reserpine impairs spatial working memory performance in monkeys: reversal by the α-2 adrenergic agonist clonidine. Brain Res.614, 191–196 (1993).
   PubMed Web of Science ®Google Scholar
• Aoki C, Venkatesan C, Go C-G et al. Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons. Cereb. Cortex8, 269–277 (1998).
   PubMedGoogle Scholar
• Aston-Jones G, Rajkowski J, Cohen J. Locus coeruleus and regulation of behavioral flexibility and attention. Prog. Brain Res.126, 165–182 (2000).
   PubMed Web of Science ®Google Scholar
• Vijayraghavan S, Wang M, Birnbaum SG et al. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat. Neurosci.10, 376–384 (2007).
   PubMed Web of Science ®Google Scholar
• Schultz W. The phasic reward signal of primate dopamine neurons. Adv. Pharmacol.42, 686–690 (1998).
   PubMedGoogle Scholar
• Goldstein LE, Rasmusson AM, Bunney SB et al. Role of the amygdala in the coordination of behavioral, neuroendocrine and prefrontal cortical monoamine responses to psychological stress in the rat. J. Neurosci.16, 4787–4798 (1996).
   PubMed Web of Science ®Google Scholar
• Brischoux F, Chakraborty S, Brierley DI et al. Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc. Natl Acad. Sci. USA106(12), 4894–4899 (2009).
   PubMed Web of Science ®Google Scholar
• Birnbaum SB, Yuan P, Bloom A et al. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science306, 882–884 (2004).
   PubMedGoogle Scholar
• Arnsten AF. Stress signaling pathways that impair prefrontal cortex structure and function. Nat. Rev. Neurosci.32, 267–287 (2009).
   Google Scholar
• Ferry B, Roozendaal B, McGaugh JL. Basolateral amygdala noradrenergic influences on memory storage are mediated by an interaction between β- and α-1-adrenoceptors. J. Neurosci.19, 5119–5123 (1999).
   PubMedGoogle Scholar
• Nader K, LeDoux JE. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations. Behav. Neurosci.113, 891–901 (1999).
   PubMedGoogle Scholar
• Faber ES. Functional interplay between NMDA receptors, SK channels and voltage-gated Ca2+ channels regulates synaptic excitability in the medial prefrontal cortex. J. Physiol.588, 1281–1292 (2010).
   PubMedGoogle Scholar
• Hagenston AM, Fitzpatrick JS, Yeckel MF. MGluR-mediated calcium waves that invade the soma regulate firing in layer V medial prefrontal cortical pyramidal neurons. Cereb. Cortex18, 407–423 (2008).
   PubMedGoogle Scholar
• Ramos B, Stark D, Verduzco L et al. α-2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals. Learn. Mem.13, 770–776 (2006).
   PubMed Web of Science ®Google Scholar
• Rama P, Linnankoski I, Tanila H et al. Medetomidine, atipamezole, and guanfacine in delayed response performance of aged monkeys. Pharmacol. Biochem. Behav.54, 1–7 (1996).
   Google Scholar
• O’Neill J, Fitten LJ, Siembieda DW et al. Effects of guanfacine on three forms of distraction in the aging macaque. Life Sci.67, 877–885 (2000).
   PubMedGoogle Scholar
• Jakala P, Riekkinen M, Sirvio J et al. Guanfacine, but not clonidine, improves planning and working memory performance in humans. Neuropsychopharmacology20, 460–470 (1999).
   PubMedGoogle Scholar
• Avery RA, Franowicz JS, Studholme C et al. The α-2A-adenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task. Neuropsychopharmacology23, 240–249 (2000).
   PubMed Web of Science ®Google Scholar
• Swartz BE, Kovalik E, Thomas K et al. The effects of an α-2 adrenergic agonist, guanfacine, on rCBF in human cortex in normal controls and subjects with focal epilepsy. Neuropsychopharmacology23, 263–275 (2000).
   PubMedGoogle Scholar
• Clerkin SM, Schulz KP, Halperin JM et al. Guanfacine potentiates the activation of prefrontal cortex evoked by warning signals. Biol. Psychiatry66, 307–312 (2009).
   PubMed Web of Science ®Google Scholar
• Mao Z-M, Arnsten AFT, Li BM. Local infusion of α-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys. Biol. Psychiatry46, 1259–1265 (1999).
   PubMedGoogle Scholar
• Steere JC, Arnsten AF. The α-2A noradrenergic agonist, guanfacine, improves visual object discrimination reversal performance in rhesus monkeys. Behav. Neurosci.111, 1–9 (1997).
   Google Scholar
• Li BM, Mao ZM, Wang M et al. α-2 adrenergic modulation of prefrontal cortical neuronal activity related to spatial working memory in monkeys. Neuropsychopharmacology21, 601–610 (1999).
   PubMedGoogle Scholar
• Ma CL, Qi XL, Peng JY et al. Selective deficit in no-go performance induced by blockade of prefrontal cortical α2-adrenoceptors in monkeys. Neuroreport14, 1013–1016 (2003).
   PubMed Web of Science ®Google Scholar
• Ma CL, Arnsten AF, Li BM. Locomotor hyperactivity induced by blockade of prefrontal cortical α-2-adrenoceptors in monkeys. Biol. Psychiatry57, 192–195 (2005).
   PubMedGoogle Scholar
• Kopecková M, Paclt I, Goetz P. Polymorphisms of dopamine-β-hydroxylase in ADHD children. Folia Biol. (Praha)52, 194–210 (2006).
   PubMedGoogle Scholar
• Comings DE, Gade-Andavolu R, Gonzalez N et al. Additive effect of three noradrenergic genes (ADRA2A, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects. Clin. Genet.55, 160–172 (1999).
   PubMed Web of Science ®Google Scholar
• Daly G, Hawi Z, Fitzgerald M et al. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol. Psychiatry4, 192–196. (1999).
   PubMed Web of Science ®Google Scholar
• Roman T, Schmitz M, Polanczyk GV et al. Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-β-hydroxylase gene. Am. J. Med. Genet.114, 154–158. (2002).
   PubMed Web of Science ®Google Scholar
• Greene CM, Bellgrove MA, Gill M et al. Noradrenergic genotype predicts lapses in sustained attention. Neuropsychologia47, 591–594 (2009).
   PubMed Web of Science ®Google Scholar
• Hess C, Reif A, Strobel A et al. A functional dopamine-β-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J. Neural Transm.116, 121–130 (2009).
   PubMed Web of Science ®Google Scholar
• Kieling C, Genro JP, Hutz MH et al. The -1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B, 485–490 (2008).
   PubMedGoogle Scholar
• Roman T, Schmitz M, Polanczyk GV et al. Is the α-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder? Am. J. Med. Genet. B Neuropsychiatr. Genet.120, 116–120 (2003).
   Google Scholar
• Park L, Nigg JT, Waldman ID et al. Association and linkage of α-2A adrenergic receptor gene polymorphisms with childhood ADHD. Mol. Psychiatry10, 572–580 (2005).
   PubMedGoogle Scholar
• Deupree JD, Smith SD, Kratochvil CJ et al. Possible involvement of α-2A adrenergic receptors in attention deficit hyperactivity disorder: radioligand binding and polymorphism studies. Am. J. Med. Genet. B Neuropsychiatr. Genet.141B, 877–884 (2006).
   PubMedGoogle Scholar
• Waldman ID, Nigg JT, Gizer IR et al. The adrenergic receptor α-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD. Cogn. Affect. Behav. Neurosci.6, 18–30 (2006).
   PubMed Web of Science ®Google Scholar
• Hunt RD, Mindera RB, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity: reports of a double-blind placebo-crossover therapeutic trial. J. Am. Acad. Child Psychiatry24, 617–629 (1985).
   PubMedGoogle Scholar
• Cohen DJ, Young JG, Nathanson JA et al. Clonidine in Tourette’s syndrome. Lancet2, 551–553 (1979).
   PubMedGoogle Scholar
• Cedarbaum JM, Aghajanian GK. Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. Eur. J. Pharmacol.44, 375–385 (1977).
   PubMed Web of Science ®Google Scholar
• Aghajanian GK. Central noradrenergic neurons: a locus for the functional interplay between α-2 adrenoceptors and opiate receptors. J. Clin. Psychiatry43, 20–24 (1982).
   PubMed Web of Science ®Google Scholar
• Cohen DJ. Sterling Lecture, February 27, 2001 “Into life: autism, Tourette’s syndrome and the community of clinical research”. Isr. J. Psychiatry38, 226–234 (2001).
   Google Scholar
• Hunt RD, Capper L, O’Connell P. Clonidine in child and adolescent psychiatry. J. Child Adolesc. Psychiatry1, 87–102 (1990).
   Google Scholar
• Bymaster FP, Katner JS, Nelson DL et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology27, 699–711 (2002).
   PubMed Web of Science ®Google Scholar
• Berridge CW, Devilbiss DM, Andrzejewski ME et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol. Psychiatry60, 1111–1120 (2006).
   PubMed Web of Science ®Google Scholar
• Mehta MA, Goodyer IM, Sahakian BJ. Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J. Child Psychol. Psychiatry45, 293–305 (2004).
   PubMed Web of Science ®Google Scholar
• Mehta MA, Owen AM, Sahakian BJ et al. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J. Neurosci.20, RC65 (2000).
   PubMed Web of Science ®Google Scholar
• Chamberlain SR, Del Campo N, Dowson J et al. Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol. Psychiatry62, 977–984 (2007).
   PubMed Web of Science ®Google Scholar
• Devilbiss DM, Berridge CW. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness. Biol. Psychiatry64, 626–635 (2008).
   PubMed Web of Science ®Google Scholar
• Arnsten AF, Dudley AG. Methylphenidate improves prefrontal cortical cognitive function through a2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder. Behav. Brain Funct.1, 2 (2005).
   PubMed Web of Science ®Google Scholar
• Gamo NJ, Wang M, Arnsten AF. Methylphenidate and atomoxetine improve prefrontal cortical function via noradrenergic α-2 and dopaminergic D1 receptor stimulation. J. Am. Acad. Child Adolesc. Psychiatry (2010) (In press).
   PubMedGoogle Scholar
• Volkow ND, Fowler JS, Wang GJ et al. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Eur. Neuropsychopharmacol.12, 557–566 (2002).
   PubMed Web of Science ®Google Scholar
• Zhu J, Reith ME. Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse. CNS Neurol. Disord. Drug Targets7, 393–409 (2008).
   PubMedGoogle Scholar
• Polanczyk G, Zeni C, Genro JP et al. Association of the adrenergic α2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry64, 218–224 (2007).
   PubMed Web of Science ®Google Scholar
• Uhlen S, Wikberg JE. Delineation of rat kidney α 2A and α 2B-adrenoceptors with [3H]RX821002 radioligand binding: computer modeling reveals that guanfacine is an α-2A-selective compound. Eur. J. Pharmacol.202, 235–243 (1991).
   PubMedGoogle Scholar
• Uhlén S, Muceniece R, Rangel N et al. Comparison of the binding activities of some drugs on α 2A, α 2B and α 2C-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig. Pharmacol. Toxicol.76, 353–364 (1995).
   PubMedGoogle Scholar
• Jasper JR, Lesnick JD, Chang LK et al. Ligand efficacy and potency at recombinant α2 adrenergic receptors: agonist-mediated [35S]GTPgS binding. Biochem. Pharmacol.55, 1035–1043 (1998).
   PubMed Web of Science ®Google Scholar
• Sorkin EM, Heel RC. Guanfacine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs31, 301–336 (1986).
   PubMed Web of Science ®Google Scholar
• Hunt RD, Arnsten AF, Asbell MD. An open trial of guanfacine in the treatment of attention deficit hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry34, 50–54 (1995).
   PubMed Web of Science ®Google Scholar
• Scahill L, Chappell PB, Kim YS et al. Guanfacine in the treatment of children with tic disorders and ADHD: a placebo-controlled study. Am. J. Psychiatry158, 1067–1074 (2001).
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Greenbaum M, Ginsberg LD et al. Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. J. Child Adolesc. Psychopharmacol.19, 501–510 (2009).
   PubMed Web of Science ®Google Scholar
• Biederman J, Melmed RD, Patel A et al. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics121, e73–e84 (2008).
   PubMed Web of Science ®Google Scholar
• Sallee FR, McGough JJ, Wigal T et al. Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: a placebo-controlled trial. J. Am. Acad. Child Adolesc. Psychiatry48, 155–165 (2009).
   PubMed Web of Science ®Google Scholar
• Wigal SB. Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. CNS Drugs23(Suppl. 1), 21–31 (2009).
   PubMed Web of Science ®Google Scholar
• Birnbaum SG, Arnsten AF. The α-2A noradrenergic agonist, guanfacine, reverses the working memory deficits induced by pharmacological stress (FG7142). Soc. Neurosci. Abstracts22, 1126 (1996).
   Google Scholar
• Rubia K, Smith AB, Halari R et al. Disorder-specific dissociation of orbitofrontal dysfunction in boys with pure conduct disorder during reward and ventrolateral prefrontal dysfunction in boys with pure ADHD during sustained attention. Am. J. Psychiatry166, 83–94 (2009).
   PubMed Web of Science ®Google Scholar
• Sofuoglu M. Cognitive enhancement as a pharmacotherapy target for stimulant addiction. Addiction105, 38–48 (2010).
   PubMed Web of Science ®Google Scholar
• Sinha R. The role of stress in addiction relapse. Curr. Psychiatry Rep.9, 388–395 (2007).
   PubMedGoogle Scholar
• Scahill L, Aman MG, McDougle CJ et al. A prospective open trial of guanfacine in children with pervasive developmental disorders. J. Child Adolesc. Psychopharmacol.16, 589–598 (2006).
   PubMed Web of Science ®Google Scholar
• McCracken JT, Aman MG, McDougle CJ et al. Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity. J. Child Adolesc. Psychopharmacol.20, 1–5 (2010).
   PubMedGoogle Scholar
• Malhotra PA, Parton AD, Greenwood R et al. Noradrenergic modulation of space exploration in visual neglect. Ann. Neurol.59, 186–190 (2006).
   PubMed Web of Science ®Google Scholar
• Singh-Curry V, Malhotra P, Farmer SF et al. Attention deficits following ADEM ameliorated by guanfacine. J. Neurol. Neurosurg. Psychiatry DOI: 10.1136/jnnp.2009.195792 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Moore TL, Killiany RJ, Herndon JG et al. Executive system dysfunction occurs as early as middle-age in the rhesus monkey. Neurobiol. Aging27, 1484–1493 (2006).
   PubMedGoogle Scholar
• West RL. An application of prefrontal cortex function theory to cognitive aging. Psychol. Bull.120, 272–292 (1996).
   PubMed Web of Science ®Google Scholar
• Daviss WB, Patel NC, Robb AS et al. Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis. J. Am. Acad. Child Adolesc. Psychiatry47, 189–198 (2008).
   PubMed Web of Science ®Google Scholar
• Klein-Schwartz W. Trends and toxic effects from pediatric clonidine exposures. Arch. Pediatr. Adolesc. Med.156, 392–396 (2002).
   PubMed Web of Science ®Google Scholar
• Sallee FR, Lyne A, Wigal T et al. Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. J. Child Adolesc. Psychopharmacol.19, 215–226 (2009).
   PubMed Web of Science ®Google Scholar
• van Zwieten PA, Chalmers JP. Different types of centrally acting antihypertensives and their targets in the central nervous system. Cardiovasc. Drugs Ther.8, 787–799 (1994).
   PubMed Web of Science ®Google Scholar
• Bradley C. The behavior of children receiving benzedrine. Am. J. Psychiatry94, 577–585 (1937).
   Google Scholar
• Arnsten AF, Ramos B, Birnbaum SB et al. Protein kinase A as a therapeutic target for memory disorders: rationale and challenges. Trends Mol. Med.11, 121–128 (2005).
   PubMedGoogle Scholar
• Giedd JN, Lalonde FM, Celano MJ et al. Anatomical brain magnetic resonance imaging of typically developing children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry48, 465–470 (2009).
   PubMed Web of Science ®Google Scholar
• Millar JK, Pickard BS, Mackie S et al.DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science310, 1187–1191 (2005).
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Xu L, Cascella N et al. DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J. Comp. Neurol.497, 436–450 (2006).
   PubMedGoogle Scholar
• Murdoch H, Mackie S, Collins DM et al. Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels. J. Neurosci.27, 9513–9524 (2007).
   PubMed Web of Science ®Google Scholar
• Lambe EK, Olausson P, Horst NK et al. Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat. J. Neurosci.25, 5225–5229 (2005).
   PubMedGoogle Scholar
• Pons S, Fattore L, Cossu G et al. Crucial role of α4 and α6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J. Neurosci.28, 12318–12327 (2008).
   PubMed Web of Science ®Google Scholar
• Clarke HF, Walker SC, Dalley JW et al. Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. Cereb. Cortex17, 18–27 (2007).
   PubMed Web of Science ®Google Scholar
• McClure MM, Barch DM, Romero MJ et al. The effects of guanfacine on context processing abnormalities in schizotypal personality disorder. Biol. Psychiatry61, 1157–1160 (2007).
   PubMed Web of Science ®Google Scholar
• Swartz BE, McDonald CR, Patel A et al. The effects of guanfacine on working memory performance in patients with localization-related epilepsy and healthy controls. Clin. Neuropharmacol.31, 251–260 (2008).
   PubMedGoogle Scholar
• Arnsten AF, Contant TA. α-2 adrenergic agonists decrease distractability in aged monkeys performing a delayed response task. Psychopharmacology108, 159–169 (1992).
   PubMed Web of Science ®Google Scholar
• Taylor FB, Russo J. Comparing guanfacine and dextroamphetamine for the treatment of adult attention deficit-hyperactivity disorder. J. Clin. Psychopharm.21, 223–228 (2001).
   PubMed Web of Science ®Google Scholar
• Wang M, Tang ZX, Li BM. Enhanced visuomotor associative learning following stimulation of α 2A-adrenoceptors in the ventral prefrontal cortex in monkeys. Brain Res.1024, 176–182 (2004).
   PubMedGoogle Scholar